ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Feb 07, 2018 Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018

Jan 30, 2018 Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study

Jan 10, 2018 Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

Jan 02, 2018 Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP

Nov 09, 2017 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017

Nov 07, 2017 CORRECTING and REPLACING - Elite Pharmaceuticals, Inc.

Nov 07, 2017 Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017

Sep 20, 2017 Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release

Aug 30, 2017 Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference

Aug 09, 2017 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information

1 2 3 4 5 6 7 8 9 10 11

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.